Concepedia

Bertolt Kreft

BK

Statistics

Publications

22

Citations

2.3K

H-Index

15

Active since

1994

Affiliations

Bayer (Germany)(Current)

Heidelberg University

German Cancer Research Center

Freie Universität Berlin

Humboldt-Universität zu Berlin

Bertolt Kreft is an author at Bayer (Germany) specializing in oncology, medicine, and molecular oncology.

Publications per year

1994–2024

22

Publications

22

P120 Catenin Regulates the Actin Cytoskeleton via Rho Family Gtpases

Nicole Noren Hooten, Betty P. Liu, Keith Burridge et al. · The Journal of Cell Biology · 2000 · 561 citations · Full text

, , +17

Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1

Olivier Kassel, Alessandra Sancono, Jörn Krätzschmar et al. · The EMBO Journal · 2001 · 475 citations · Full text

, , +12

Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Sven Golfier, Charlotte Kopitz, Antje Kahnert et al. · Molecular Cancer Therapeutics · 2014 · 253 citations

, , +17

Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine.

Dietmar Berndorff, Bertolt Kreft, N. Schnoy et al. · The Journal of Cell Biology · 1994 · 185 citations · Full text

, , +17

Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity

Antje M. Wengner, Gerhard Siemeister, Marcus Koppitz et al. · Molecular Cancer Therapeutics · 2016 · 118 citations · Full text

, , +17

1–5 of 22